3rd Operationalize: Decentralized Clinical Trials

We all know that decentralized clinical trials offer a plethora of advantages to trial participants and sponsors. What we don’t know is how to simplify regulatory understanding, streamline internal protocols, restructure recruitment processes, improve patient communication and address all the other operational challenges preventing us from fully capitalizing on this moment.

That’s why each year DCT pioneers from pharma, CROs, tech providers and patient advocacy groups gather at the annual Operationalize: Decentralized Clinical Trials Summit to share lessons learned and best practice case studies to move the industry forward.

This September, join over 150 DCT leaders to hear exclusive case-studies and engage in open discussions offering practical, implementable, and grounded insights. With each and every session offering take-home lessons, this is your best opportunity to clarify the complex issues through end-to-end hybrid and siteless clinical trial program operationalization.

Whether you’re struggling with trial set-up, technological integration, negotiating with stakeholders, hybridization, patient communication, or choice provision: ensure you aren’t repeating past mistakes by hearing global leaders recall their experiences with a shared goal of providing you with pragmatic solutions to solve these complex hurdles.

Website https://go.evvnt.com/1114093-0?pid=176 
Tickets https://go.evvnt.com/1114093-2?pid=176 
Brochure https://go.evvnt.com/1114093-3?pid=176 

Prices:
Drug Developer + Academic & Researcher - Conference Only USD 349.00
Service & Solution Providers - Conference Only USD 3599.00

Speakers: Alan Go, Regional Medical Director, Kaiser Permanente, Anna Yang, Senior Medical Science Director, Genentech, Daniel Karlin, Chief Medical Officer, MindMed, Esther Howard, Oncology Advisor, THREAD Research, Hassan Kadhim, Senior Director, Head of Clinical Trial Business Capabilities, Bristol Myers Squibb, Heidi Johnson, Director, DCT Operations, DCT Strategy & Implementation, Bayer, Imran Shakur, Associate Director, Clinical Supply Capabilities, Biogen, Isaac Rodriguez- Chavez, Senior Vice President of Scientific & Clinical Affairs, ICON, James Hacunda, Data Sciences Institute, Research & Development Digital Strategy Lead, Takeda, Jeremy Price, Senior Director, Clinical Innovation & Strategic Partnerships, Pfizer, Lewis Millen, Global Clinical Sciences & Operations Lead, UCB, Maimah Karmo, Patient Advocate & CEO, Tigerlily Foundation, Rakesh Maniar, Head of eClinical Technologies, Global Data Management & Standards, Clinical Trial Operations, Merck, Sandeep Bhat, Senior Leader, Digital Engagement, Implementation & Global Clinical Operations, GSK, Savo Topic, Associate Director Digital Strategy, R&D, Takeda, Syneos Health Representative, Taras Carpiac, Executive Director, Global Development Operations, Amgen, Tracey Robertson, Global Clinical Development & Operations Patient & Site Engagement Process Lead, Boehringer Ingelheim, TrialCard Representative, Wendi Lau, Senior Director Clinical Development Operations, TA Lead Specialty Medicine, AbbVie

Dates and Time: Starts: Wed, Sep 7, 2022 ( 8:50 AM) and Ends: Thu, Sep 8, 2022 ( 5:00 PM)

Venue details: Hyatt Regency Boston